Exámenes de laboratorio en patología articular

Aho, 1999, Antifilaggrin antibodies in recent-onset arthritis, Scand J Rheumatol, 28, 113, 10.1080/030097499442586 Aho, 1993, Antikeratin antibody and antiperinuclear factor as markers for subliclinical rheumatoid disease process, J Rheumatol, 20, 1278 Alnigenis, 2000, Antiperinuclear factor and antikeratin antibody: diagnostic use in a clinical laboratory setting, J Rheumatol, 21, 2056 Amoura, 1997, Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus. Correlation with serum antinucleosome antibody titers and absence of clear association with disease activity, Arthritis Rheum, 40, 2217, 10.1002/art.1780401217 Arnoux, 2000, Les anticorps « antiphospholipides » : íntérèt clinique et diagnostic biologique, Ann Biol Clin, 58, 557 Berthelot, 1998, Valeur des anticorps anti-périnucléaires au 1:100 pour le diagnostic depolyarthriterhumatoiíde. Étude de 600 patients et méta-analyse de la littérature, Rev Rhum Mal Ostéoartic, 65, 9 Berthelot, 1997, Antiperinuclear factors are present in polyarthritis before ACR criteria for rheumatoid arthritis are fuffilled, Ann Rheum Dis, 56, 123, 10.1136/ard.56.2.123 Boomsma, 2000, Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels. A prospective study, Arthritis Rheum, 43, 2025, 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O Cervera, 2002, Antiphospholipid syndrome. Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1 000 patients, Arthritis Rheum, 46, 1019, 10.1002/art.10187 Choi, 2001, Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: meta-analysis with a focus on antimyeloperoxidase antibodies, J Rheumatol, 28, 1584 Cordonnier, 1996, Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor, Br J Rheumatol, 35, 620, 10.1093/rheumatology/35.7.620 De Bandt, 1998, Les anticorps anti-cytoplasme des polynucléaires (ANCA), Rev Rhum Mal Ostéoartic, 65, 457 Desprès, 1994, The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis, J Rheumatol, 21, 1027 Després, 1995, Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera, J Clin Invest, 95, 1891, 10.1172/JCI117870 Emfen, 1997, Clinical significance of antibodies. Comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays, Arthritis Rheum, 40, 1612, 10.1002/art.1780400910 Forslind, 2000, Antifilaggrin autoantibodies in early rheumatoid arthritis, Scand J Rheumatol, 29, 320, 10.1080/030097400447714 Girard, 2001, Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study, Rheumatology, 40, 147, 10.1093/rheumatology/40.2.147 Goldbach-Mansky, 2000, Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset, Arthritis Res, 2, 236, 10.1186/ar93 Hassfeld, 1993, Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis, Br J Rheumatol, 32, 199, 10.1093/rheumatology/32.3.199 Hassfeld, 1989, Demonstration of a new antinuclear antibody (anti-RA 33) that is highly specific for rheumatoid arthritis, Arthritis Rheum, 32, 1515, 10.1002/anr.1780321204 Hayem, 1999, Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis, J Rheumatol, 26, 7 Hepburn, 2002, Antinuclear factor, Rheumatology, 41, 343, 10.1093/rheumatology/41.3.343 Hirata, 1992, Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease, Arthritis Rheum, 35, 449, 10.1002/art.1780350415 Hoet, 1992, Theantiperinuclear factor(APF) and antikeratin antibodies (AKA) in rheumatoid arthritis Hoffman, 1998, Antineutrophil cytoplasmic antibodies, Arthritis Rheum, 41, 1521, 10.1002/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A Hueber, 1999, Sensitivity and specificity of anti-Sa autoantibodies for rheumatoid arthritis, Rheumatology, 38, 155, 10.1093/rheumatology/38.2.155 Johanet, 2000, Signification clinique des anticorps antiribosomes, Rev Méd Interne, 21, 510, 10.1016/S0248-8663(00)89226-7 Jonsson, 1998, Combined elevation of IgM and IgA rheumatoid factor has high diagnostic specificity for rheumatoid arthritis, Rheumatol Int, 18, 119, 10.1007/s002960050069 Kerr, 1993, Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis, Arthritis Rheum, 36, 365, 10.1002/art.1780360312 Klein Gunnewiek, 1997, The U1 snRNP complex: an autoantigen in connective tissue diseases. An update, Clin Exp Rheumatol, 15, 549 Kroot, 2000, The prognostic value of anticyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis, Arthritis Rheum, 43, 1831, 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6 Kuwana, 1993, Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis, J Clin Invest, 91, 1399, 10.1172/JCI116343 Kuwana, 1994, Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis, Arthritis Rheum, 37, 75, 10.1002/art.1780370111 Kyndt, 1999, Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis, Am J Med, 106, 527, 10.1016/S0002-9343(99)00064-9 Le Goff, 1986, Étude de la précocité d'apparition des anticorps antikératine, Rev Rhum Mal Ostéoartic, 53, 699 Lee, 2001, Isotypes of anti-β2 glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus, J Rheumatol, 28, 520 Love, 1991, A new approach to the classification of idiopathic inflammatory myopathy: myositis specific autoantibodies define useful homogeneous patient group, Medicine, 70, 360, 10.1097/00005792-199111000-00002 Masson-Bessière, 2000, In the rheumatoid pann us, antifilaggrin autoantibodies are produced by local plasma cellsand constitue a higher proportion of IgG than in synovial fluid and serum, Clin Exp Immunol, 119, 544, 10.1046/j.1365-2249.2000.01171.x McLaren, 2001, The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting, Q J Med, 94, 615, 10.1093/qjmed/94.11.615 Menard, 2000, Insights into rheumatoid arthritis derived from the Sa immune system, Arthritis Res, 2, 429, 10.1186/ar122 Meyer, 1986, Les anticorps anti-kératine. Un marqueur des poryarthrites rhumatoïdes évolutives, Rev Rhum Mal Ostéoartic, 53, 601 Mimori, 1995, Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases, Proc Natl Acad Sci USA, 92, 7267, 10.1073/pnas.92.16.7267 Min, 2002, Antinucleosome antibody: significance in lupus patients lac king anti-double-stranded DNA antibody, Clin Exp Rheumatol, 20, 13 Morozzi, 2000, Comparison of different methods for the detection of anti-Ro/SSA antibodies in connective tissue diseases, Clin Exp Rheumatol, 18, 729 Okano, 1993, Autoantibody reactive with RNA polymerase III in systemic sclerosis, Ann Intern Med, 119, 1005, 10.7326/0003-4819-119-10-199311150-00007 Paimela, 2001, Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis, Ann Rheum Dis, 60, 32, 10.1136/ard.60.1.32 Palosuo, 1998, Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay, Int Arch Allergy Immunol, 115, 294, 10.1159/000069460 Parekh, 1998, Galactosylation of IgG associated oligosaccharides : reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity, Lancet, 351, 966 Rao, 1995, A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener'sgranulomatosis, Lancet, 346, 926, 10.1016/S0140-6736(95)91555-9 Reichlin, 2002, ENA: its place in medicine, Lupus, 11, 201, 10.1191/0961203302lu196em Reparon-Schuijt, 2001, Secretion of anti-citruiline containing peptide antibody by B lymphocytes in rheumatoid arthritis, Arthritis Rheum, 44, 41, 10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0 Saraux, 1995, How useful are tests for rheumatoid factors, antiperinuclear factors, antikeratin antibody, and the HLA DR4 antigen for the diagnosis of rheumatoidarthritis?, Rev Rhum [engl ed], 62, 16 Schellekens, 1998, Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies, J Clin Invest, 101, 273, 10.1172/JCI1316 Schellekens, 2000, The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide, Arthritis Rheum, 43, 155, 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3 Schönermarck, 2001, Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase -ANCA, Rheumatology, 40, 178, 10.1093/rheumatology/40.2.178 Scofield, 1999, Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins, Arthritis Rheum, 42, 199, 10.1002/1529-0131(199902)42:2<199::AID-ANR1>3.0.CO;2-1 Segelmark, 2000, How and why should we detect ANCA?, Clin Exp Rheumatol, 18, 629 Serre, 2001, Autoanticorps antifilaggrine/antifibrine déiminée. Outre leurintérêt diagnostique et pronostique, les autoanticorps antifilaggrine/antifibrine déiminée (AFA) sont probablement impliques dans la physiopathogénie rhumatoïde, Rev Rhum Mal Ostéoartic, 68, 201, 10.1016/S1169-8330(01)00131-4 Shmerling, 1992, How useful is the rheumatoid factor ? An analysis of sensitivity, specificity and predictive value, Arch Intern Med, 152, 2417, 10.1001/archinte.1992.00400240041006 Shmerling, 1991, The rheumatoid factor: an analysis of clinical utility, Am J Med, 91, 528, 10.1016/0002-9343(91)90190-9 Smeenk, 2002, Detection of antibodies to dsDNA: current insights into its relevance, Clin Exp Rheumotol, 20, 294 Spencer-Grenn, 1997, Test performance in systemic sclerosis: anti-centromere and anti-Scl 70 antibodies, Am J Med, 103, 242, 10.1016/S0002-9343(97)00023-5 Steen, 1988, Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis, Arthritis Rheum, 31, 196, 10.1002/art.1780310207 Tan, 1998, The LE cell and its legacy, Clin Exp Rheumatol, 16, 652 Tan, 1980, Diversity of antinuclear antibodies in progressive systemic scierosis. Anti-centromere antibody and its relationship to CREST syndrome, Arthritis Rheum, 23, 617, 10.1002/art.1780230602 Tan, 1999, A critical evaluation of enryme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity and specificity, Arthritís Rheum, 42, 455, 10.1002/1529-0131(199904)42:3<455::AID-ANR10>3.0.CO;2-3 Tan, 2002, A critical evaluation of enryme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content, J Rheumatol, 29, 68 Tubach, 2000, IgG antiβ2 glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value tor the antiphospholipid syndrome, J Rheumatol, 27, 1437 Vaile, 2000, Is high titre ANA specific for connective tissue disease?, Clin Exp Rheumatol, 18, 433 Van Jaarsveld, 1999, The pronostic value of the anticitruilinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis, Clin Exp Rheumatol, 17, 689 Vncent, 1999, Anti-perinuclear fador compared with the so called ·antikeratin·antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides, Ann Rheum Dis, 58, 42, 10.1136/ard.58.1.42 Vincent, 1998, Immunogblotting detection of autoantibodies to human epidermis filaggrin : a new diagnostic test for rheumatoid arthritis, J Rheumatol, 25, 838 Vittecoq, 2001, Rev Rhum Mal Ostéoartic, 68, 239, 10.1016/S1169-8330(01)00002-3 Von Essen, 1993, Prospect for an additional laboratory criterio for rheumatoid arthritis, Scand J Rheumatol, 22, 267, 10.3109/03009749309095137 Wiik, 2002, Rational use of ANCA in the diagnosis of vasculitis, Rheumotology, 41, 481, 10.1093/rheumatology/41.5.481 Young, 1991, Agalactosyl IgG : an aid to differential diagnosis in early synovitis, Arthritis Rheum, 34, 1425, 10.1002/art.1780341113